Table 3 Risk evaluation in categorized groups for the original cohort and sub-cohort.

From: Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study

 

Score

Cohort (2011–2020)

Sub-cohort (2014–2020)

OR*

p-value

OR*

p-value

Intermediate-1

0.5–6

1.29 [1.25, 1.34]

 < 0.001

1.28 [1.23, 1.33]

 < 0.001

Intermediate-2

6–14

3.07 [2.67–3.52]

 < 0.001

2.88 [2.48, 3.32]

 < 0.001

High

 > 14

4.62 [3.14, 6.68]

 < 0.001

4.16 [2.77, 6.11]

 < 0.001

  1. *Based on the group without any risk factors (Score ≤ 0).
Back to article page